Completed PHASE1/PHASE2 INTERVENTIONAL NCT00308542

A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.

Updated 5 times since 2017 Last updated: Feb 9, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Diabetic Macular Edema, this trial is completed. The trial is conducted by Sanwa Kagaku Kenkyusho Co., Ltd. and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanwa Kagaku Kenkyusho Co., Ltd.

Data source: Sanwa Kagaku Kenkyusho Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aichi, Japan , Chiba, Japan , Fukuoka, Japan , Gunma, Japan , Hokkaido, Japan , Kagawa, Japan , Kyoto, Japan , Mie, Japan , Miyazaki, Japan , Osaka, Japan and 2 more locations